A powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
Details for Australian Patent Application No. 2006270162 (hide)
International Classifications
Event Publications
7 February 2008 PCT application entered the National Phase
PCT publication WO2007/011740 Priority application(s): WO2007/011740
28 April 2011 Assignment before Grant
Board of Regents, The University of Texas System; Mission Pharmacal Co. The application has been assigned to The Board of Regents of The University of Texas System
12 January 2012 Application Accepted
Published as AU-B-2006270162
10 May 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006270165-Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
2006270158-Yield increase in plants overexpressing the SHSRP genes
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser